Cargando…

Is redox signaling a feasible target for overcoming multidrug resistance in cancer chemotherapy?

Detalles Bibliográficos
Autores principales:	Polimeni, Manuela, Gazzano, Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274902/ https://www.ncbi.nlm.nih.gov/pubmed/25566078 http://dx.doi.org/10.3389/fphar.2014.00286

Ejemplares similares

Modulation of redox homeostasis: A strategy to overcome cancer drug resistance
por: Li, Yang, et al.
Publicado: (2023)

Multiple Molecular Mechanisms to Overcome Multidrug Resistance in Cancer by Natural Secondary Metabolites
por: El-Readi, Mahmoud Zaki, et al.
Publicado: (2021)

A Danshensu-Tetramethylpyrazine Conjugate DT-010 Overcomes Multidrug Resistance in Human Breast Cancer
por: Zhou, Xinhua, et al.
Publicado: (2019)

Pharmacological Strategies for Overcoming Multidrug Resistance to Chemotherapy
por: Fedotcheva, T. A., et al.
Publicado: (2023)

Gibberellin derivative GA-13315 overcomes multidrug resistance in breast cancer by up-regulating BMP6 expression
por: Luo, Xianqiang, et al.
Publicado: (2022)

Combating and overcoming drug resistance in cancer
por: Price, Douglas K.
Publicado: (2014)

Adjudin-loaded redox-sensitive paclitaxel-prodrug micelles for overcoming multidrug resistance with efficient targeted Colon cancer therapy
por: Chen, Deli, et al.
Publicado: (2020)

Targeting Tumor Associated Macrophages to Overcome Conventional Treatment Resistance in Glioblastoma
por: Grégoire, Hélène, et al.
Publicado: (2020)

Nanoparticles overcome adaptive immune resistance and enhance immunotherapy via targeting tumor microenvironment in lung cancer
por: Zhang, Xin, et al.
Publicado: (2023)

Cancer Stem Cells as a Potential Target to Overcome Multidrug Resistance
por: Cho, Yena, et al.
Publicado: (2020)

Ginsenoside Rg5 overcomes chemotherapeutic multidrug resistance mediated by ABCB1 transporter: in vitro and in vivo study
por: Feng, Sen-Ling, et al.
Publicado: (2020)

Targeting Ubiquitin-Specific Protease 7 (USP7) in Cancer: A New Insight to Overcome Drug Resistance
por: Lu, Jiabin, et al.
Publicado: (2021)

IGF2BP1, a New Target to Overcome Drug Resistance in Melanoma?
por: Xi, Yufeng, et al.
Publicado: (2022)

Nanodrug delivery in reversing multidrug resistance in cancer cells
por: Kapse-Mistry, Sonali, et al.
Publicado: (2014)

Overcoming Multidrug Resistance in Cancer Stem Cells
por: Moitra, Karobi
Publicado: (2015)

Fabrication of pH/Redox Dual-Responsive Mixed Polyprodrug Micelles for Improving Cancer Chemotherapy
por: Luo, Ji, et al.
Publicado: (2022)

Therapeutic Suppression of FAK-AKT Signaling Overcomes Resistance to SHP2 Inhibition in Colorectal Carcinoma
por: Li, Ye, et al.
Publicado: (2021)

Inhibition of multidrug resistance protein 1 (MRP1) improves chemotherapy drug response in primary and recurrent glioblastoma multiforme
por: Tivnan, Amanda, et al.
Publicado: (2015)

Recent Progress of Novel Nanotechnology Challenging the Multidrug Resistance of Cancer
por: Zhang, Chengyuan, et al.
Publicado: (2022)

Targeting Mitochondrial Metabolism and RNA Polymerase POLRMT to Overcome Multidrug Resistance in Cancer
por: Yu, Hui-Jing, et al.
Publicado: (2021)

Targeting PAR2 Overcomes Gefitinib Resistance in Non-Small-Cell Lung Cancer Cells Through Inhibition of EGFR Transactivation
por: Jiang, Yuhong, et al.
Publicado: (2021)

Targeting immune cell types of tumor microenvironment to overcome resistance to PD-1/PD-L1 blockade in lung cancer
por: Wang, Man, et al.
Publicado: (2023)

Crosstalk between Wnt/β-catenin signaling pathway and DNA damage response in cancer: a new direction for overcoming therapy resistance
por: Zhang, Xixia, et al.
Publicado: (2023)

Multifunctional Nanoplatforms as a Novel Effective Approach in Photodynamic Therapy and Chemotherapy, to Overcome Multidrug Resistance in Cancer
por: Majerník, Martin, et al.
Publicado: (2022)

An Autocrine Cytokine/JAK/STAT-Signaling Induces Kynurenine Synthesis in Multidrug Resistant Human Cancer Cells
por: Campia, Ivana, et al.
Publicado: (2015)

Epoxylathyrane Derivatives as MDR-Selective Compounds for Disabling Multidrug Resistance in Cancer
por: Reis, Mariana Alves, et al.
Publicado: (2020)

Inorganic Nanocarriers Overcoming Multidrug Resistance for Cancer Theranostics
por: Lin, Gan, et al.
Publicado: (2016)

Stimuli-Responsive Nanomedicines for Overcoming Cancer Multidrug Resistance
por: Zhou, Lei, et al.
Publicado: (2018)

Targeted chemotherapy overcomes drug resistance in melanoma
por: Yue, Jingyin, et al.
Publicado: (2020)

Drug-resistant HER2-positive breast cancer: Molecular mechanisms and overcoming strategies
por: Wu, Xiaofan, et al.
Publicado: (2022)

Nanomaterials for reversion of multidrug resistance in cancer: a new hope for an old idea?
por: Conde, João, et al.
Publicado: (2013)

Glutathione: new roles in redox signaling for an old antioxidant
por: Aquilano, Katia, et al.
Publicado: (2014)

Triphenylphosphonium-modified mitochondria-targeted paclitaxel nanocrystals for overcoming multidrug resistance
por: Han, Xue, et al.
Publicado: (2019)

Crosstalk between endoplasmic reticulum stress and multidrug-resistant cancers: hope or frustration
por: Qing, Bowen, et al.
Publicado: (2023)

Nanoparticles in the Treatment of Infections Caused by Multidrug-Resistant Organisms
por: Lee, Nan-Yao, et al.
Publicado: (2019)

Plasmodium falciparum Multidrug Resistance Proteins (pfMRPs)
por: Gil, José Pedro, et al.
Publicado: (2021)

Research Progress on Natural Diterpenoids in Reversing Multidrug Resistance
por: Deng, Zhuo-fen, et al.
Publicado: (2022)

Editorial: Novel Approaches to the Treatment of Multidrug-Resistant Bacteria
por: Pusparajah, Priyia, et al.
Publicado: (2022)

TRP Channels as Sensors and Signal Integrators of Redox Status Changes
por: Takahashi, Nobuaki, et al.
Publicado: (2011)

New Approaches to Overcome Transport Related Drug Resistance in Trypanosomatid Parasites
por: Garcia-Salcedo, Jose A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_kcirme7bg5u7ehegcvogt4bcmn